Company Update

Vista Pharmaceuticals has announced a board meeting on February 13, 2026, to review and approve its financial results for the quarter and nine months ended December 31, 2025. During this meeting, the Board will also consider the Limited Review Report for the same period.

This announcement is significant for investors, as it sets the stage for the release of the company's latest financial performance metrics, providing key insights into its operational health and strategic direction.